Literature DB >> 12686439

Effect of Dai-kenchu-to (Da-Jian-Zhong-Tang) on the delayed intestinal propulsion induced by chlorpromazine in mice.

Kazuko Satoh1, Yoshio Kase, Mitsutoshi Yuzurihara, Kazushige Mizoguchi, Kouji Kurauchi, Atsushi Ishige.   

Abstract

This study was conducted to evaluate the effect of Dai-kenchu-to on chlorpromazine-induced hypoperistalsis in mice. Oral administration of Dai-kenchu-to (30-300 mg/kg) dose-dependently improved small intestinal and distal colonic propulsion decreased by chlorpromazine (3 mg/kg, p.o.). Although the improvement of small intestinal propulsion due to Dai-kenchu-to was partially inhibited by atropine (1 mg/kg, s.c.), this action was completely inhibited by the concomitant administration of lorglumide (10 mg/kg, i.p.), a CCKA receptor antagonist. The distal colonic propulsion-improving effect of Dai-kenchu-to was abolished by atropine (1 mg/kg, s.c.). When the effects of the respective components of Dai-kenchu-to were evaluated, oral administration of Zanthoxylum Fruit improved both delayed small intestinal and distal colonic propulsion caused by chlorpromazine. On the other hand, Malt Sugar was effective against only delayed small intestinal propulsion. The action of Zanthoxylum Fruit was completely inhibited by atropine (1 mg/kg, s.c.), and the effect of Malt Sugar was inhibited by lorglumide (10 mg/kg, i.p.). These results demonstrated that Dai-kenchu-to improves chlorpromazine-induced hypoperistalsis via cholinergic systems and that Zanthoxylum Fruit is the main contributor to this action of Dai-kenchu-to. In addition, endogenous CCK due to Malt Sugar may also contribute to this effect of Dai-kenchu-to.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12686439     DOI: 10.1016/s0378-8741(03)00038-2

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  13 in total

Review 1.  Japanese herbal medicine in functional gastrointestinal disorders.

Authors:  H Suzuki; J M Inadomi; T Hibi
Journal:  Neurogastroenterol Motil       Date:  2009-03-25       Impact factor: 3.598

2.  Effects of daikenchuto, a Japanese herb, on intestinal motility after total gastrectomy: a prospective randomized trial.

Authors:  Yusuke Akamaru; Tsuyoshi Takahashi; Toshirou Nishida; Takeshi Omori; Kazuhiro Nishikawa; Shoki Mikata; Noriyuki Yamamura; Satoru Miyazaki; Hiroshi Noro; Shuji Takiguchi; Masaki Mori; Yuichiro Doki
Journal:  J Gastrointest Surg       Date:  2015-01-07       Impact factor: 3.452

3.  The effects of the Kampo medicine (Japanese herbal medicine) "Daikenchuto" on the surgical inflammatory response following laparoscopic colorectal resection.

Authors:  Kozo Yoshikawa; Mitsuo Shimada; Masanori Nishioka; Nobuhiro Kurita; Takashi Iwata; Shinya Morimoto; Tomohiko Miyatani; Masato Komatsu; Hideya Kashihara; Chie Mikami
Journal:  Surg Today       Date:  2011-12-28       Impact factor: 2.549

4.  Feeding administration of Daikenchuto suppresses colitis induced by naive CD4+ T cell transfer into SCID mice.

Authors:  Tsutomu Iwasa; Haruei Ogino; Kazuhiko Nakamura; Eikichi Ihara; Hirotada Akiho; Ryoichi Takayanagi
Journal:  Dig Dis Sci       Date:  2012-05-19       Impact factor: 3.199

5.  Clinical pharmacology of daikenchuto assessed by transit analysis using radiopaque markers in patients with colon cancer undergoing open surgery: a multicenter double-blind randomized placebo-controlled study (JFMC39-0902 additional study).

Authors:  Hidetoshi Katsuno; Koutarou Maeda; Masatoshi Ohya; Kazuhiko Yoshioka; Akira Tsunoda; Keiji Koda; Hiroyoshi Matsuoka; Hiroki Ohge; Satoshi Morita; Shigetoyo Saji; Takashi Kanematsu; Masaki Kitajima
Journal:  J Gastroenterol       Date:  2015-07-11       Impact factor: 7.527

6.  Kampo medicine "Dai-kenchu-to" prevents bacterial translocation in rats.

Authors:  Kozo Yoshikawa; Nobuhiro Kurita; Jun Higashijima; Tomohiko Miyatani; Hidenori Miyamoto; Masanori Nishioka; Mitsuo Shimada
Journal:  Dig Dis Sci       Date:  2008-04-30       Impact factor: 3.199

7.  Effect of TU-100, a traditional Japanese medicine, administered after hepatic resection in patients with liver cancer: a multi-center, phase III trial (JFMC40-1001).

Authors:  Mitsuo Shimada; Yuji Morine; Hiroaki Nagano; Etsuro Hatano; Takashi Kaiho; Masaru Miyazaki; Toru Kono; Toshiya Kamiyama; Satoshi Morita; Junichi Sakamoto; Mitsuo Kusano; Shigetoyo Saji; Takashi Kanematsu; Masaki Kitajima
Journal:  Int J Clin Oncol       Date:  2014-03-06       Impact factor: 3.402

8.  Clinical efficacy of Daikenchuto for gastrointestinal dysfunction following colon surgery: a randomized, double-blind, multicenter, placebo-controlled study (JFMC39-0902).

Authors:  Hidetoshi Katsuno; Koutarou Maeda; Takashi Kaiho; Katsuyuki Kunieda; Kimihiko Funahashi; Junichi Sakamoto; Toru Kono; Hirotoshi Hasegawa; Yoshiyuki Furukawa; Yoshihiro Imazu; Satoshi Morita; Masahiko Watanabe
Journal:  Jpn J Clin Oncol       Date:  2015-05-12       Impact factor: 3.019

Review 9.  Kampo medicines for gastrointestinal tract disorders: a review of basic science and clinical evidence and their future application.

Authors:  Kazunari Tominaga; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2013-03-16       Impact factor: 7.527

10.  Traditional Japanese medicine daikenchuto improves functional constipation in poststroke patients.

Authors:  Takehiro Numata; Shin Takayama; Muneshige Tobita; Shuichi Ishida; Dai Katayose; Mitsutoshi Shinkawa; Takashi Oikawa; Takanori Aonuma; Soichiro Kaneko; Junichi Tanaka; Seiki Kanemura; Koh Iwasaki; Tadashi Ishii; Nobuo Yaegashi
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-25       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.